check_circleStudy Completed

Eczema

Bayer Identifier:

Trial_93086

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Comparison of methylprednisolone aceponate milk 1x daily, 2x daily and Betnesol® V lotion (2x daily) in the treatment of acute eczema

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

14 - N/A
  • -

  • -

Trial summary

Enrollment Goal
339
Trial Dates
June 1994 - February 1995
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Methylprednisolone aceponate milk (1x daily for 14 days): Its efficacy and tolerance in comparison to methylprednisolone aceponate milk (2x daily) and Betnesol® V lotion (2x daily) in the treatment of acute eczema - A multicenter, double-blind study
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.